Skip to main content

JPML Agrees To Centralize Elmiron Cases Over Vision Problems

JPML Agrees To Centralize Elmiron Cases Over Vision Problems

JPML Agrees To Centralize Elmiron Cases Over Vision Problems

Introduction

On Tuesday, the United States Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order, stating that the panel finds the centralization of Elmiron lawsuits in the District of New Jersey will serve the convenience of the parties and witnesses and promote the just and efficient conduct of the litigation.

Elmiron, also known by its generic name pentosan polysulfate sodium, or PPS, is an oral prescription drug used to treat pain/discomfort caused by bladder disorder interstitial cystitis, or IC. Recently, it has been discovered that the drug might lead to severe retinal injuries and permanent vision problems, following which many users have filed lawsuits.

In September, a consolidation request was filed by the plaintiffs who allege Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals for failing to warn about the side effects associated with the IC drug. The request included 63 actions pending in eleven districts, as listed on Schedule A of the attached transfer order, as well as 65 potentially-related actions. The plaintiffs asked the JPML to centralize the cases before Honorable Brian R. Martinotti in New Jersey.

The recent order notes that no responding party opposes the centralization, which will eliminate duplicative discovery, avoid inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the judiciary.

The centralization in the District of New Jersey is supported by plaintiffs in 42 actions, whereas some plaintiffs proposed alternative transferee districts of the Eastern District of Pennsylvania or the Southern District of Florida. Responding plaintiffs in 33 cases support centralization in the Eastern District of Pennsylvania, and plaintiffs in the Southern District of Ohio Gruppo action support centralization in the Southern District of Ohio.

The order concludes that the lawsuits listed on Schedule A and pending outside the District of New Jersey are transferred to the District of New Jersey and will be presided by Judge Martinotti for coordinated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!